Developing antiepileptogenic drugs for acquired epilepsy: Targeting the mammalian target of rapamycin (mTOR) pathway

Keyphrases

• Acquired Epilepsy 100%
• Antiepileptogenic 100%
• Mammalian Target of Rapamycin Signaling Pathway 100%
• Antiepileptogenic Drugs 100%
• Epileptogenesis 83%
• Epilepsy 66%
• Mammalian Target of Rapamycin (mTOR) 50%
• Brain Injury 50%
• Tuberous Sclerosis Complex 33%
• Kainate 33%
• Rapamycin 33%
• MTOR Inhibitor 33%
• Therapeutic Target 16%
• Cell Behavior 16%
• Seizure 16%
• Drug Development 16%
• Disease-modifying Therapy 16%
• Primary Cells 16%
• Synaptic Plasticity 16%
• Cell Signaling Pathways 16%
• Programmed Cell Death 16%
• Ion Channel Expression 16%
• Popular 16%
• Genetic Epilepsy 16%
• Status Epilepticus 16%
• Symptomatic Treatment 16%
• Epilepsy Type 16%
• Model Data 16%
• Translational Applications 16%
• Current Medication 16%
• Limbic Epilepsy 16%

Neuroscience

• Mammalian Target of Rapamycin 100%
• Epilepsy 100%
• Epileptogenesis 50%
• Brain Injury 30%
• Cell Signaling 20%
• Tuberous Sclerosis 20%
• Sirolimus 20%
• Cell Death 10%
• Cell Function 10%
• Ion Channel 10%
• Synaptic Plasticity 10%
• Status Epilepticus 10%
• Genetics 10%